Epilepsy drugs
Companies that develop and sell medicines to treat epilepsy and seizures, including rare forms that start in childhood.
+40.3%
over 1 year · S&P 500 +11.6%
Key indicators
Health
49 / 100
Fragile
Solid
Up over 1 year
7 of 9
Volatility
72%
Calm
Choppy
Profitability
−865%
Low
High
Health and price: against the other tags.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
The 9 companies
PRAX
+78.7%
BHVN
+73.8%
STOK
+6.2%
RAPP
+3.9%
Size: weight in the tag. Color: move over the period.
See all companies
See all companies
P
Praxis Precision Medicines
PRAX
55.0%
+78.7%
B
Biohaven
BHVN
15.9%
+73.8%
S
Stoke Therapeutics
STOK
12.1%
+6.2%
R
Rapport Therapeutics
RAPP
8.4%
+3.9%
O
Ovid Therapeutics
OVID
3.3%
+92.4%
A
Aquestive Therapeutics
AQST
3.1%
−29.9%
D
Bright Minds Biosciences
DRUG
2.2%
−61.6%
J
Jazz Pharmaceuticals
JAZZ
+76.7%
X
Xenon Pharmaceuticals Inc. Common Shares
XENE
+2.0%